The Ott Lab publishes novel research on SARS-CoV-2 variants Read More

Ott Lab News

Dr. Melanie Ott organizes successful Keystone Symposia

Dr. Ott was on the scientific organizing committee for the April 24-29, 2019 Keystone Symposia, Functional Cures and the Eradication of HIV. The meeting took place in Whistler, British Columbia, and was very well attended.

Two new members join the Ott Lab

The Ott Lab started off 2019 by adding two new postdoctoral scholars, Gili Aviv and Danielle Lyons. We are very excited to have these two join our team! Welcome, Gili and Danielle!

To learn more about our lab members, scroll over the ‘People’ button, and select ‘Lab Members’.

Ibraheem Ali gives exit talk

On December 21st, 2018, Ibs gave his exit talk, one of the final stages of completing his PhD. Ibs will continue to work in the Ott Lab as a postdoctoral scholar while he works on a manuscript for publication.

Congrats, Dr. Ali!

Melanie Ott receives Chan Zuckerberg Award

Dr. Melanie Ott was awarded a Chan Zuckerberg Intercampus Research Award for her project “Defining host responses of virus- infected and uninfected neighbor cells”. This funding from the CZ Biohub will foster further scientific research collaboration between Stanford, the University of California at Berkeley, and the University of California at San Francisco. More information about the award can be found here.

Congratulations, Dr. Ott!

Krystal Fontaine and Kristoffer Leon publish Zika paper

Krystal and Kris’ paper “The cellular NMD pathway restricts Zika virus infection and is targeted by the viral capsid protein” has been accepted for publishing by mBio! Co-authors include Mir Khalid, Sakshi Tomar, David Jimenez-Morales, Mariah Dunlap, Julia A Kaye, Priya S Shah, Steve Finkbeiner, Nevan J. Krogan, and Melanie Ott.

Congrats, Krystal and Kris!

Philip Ansumana Hull moves on to Bristol-Meyers Squibb

On June 22nd, Philip Ansumana Hull successfully defended his thesis and earned his PhD. His thesis work focused on immune aging, T cell biology, and T cell metabolism. This included identifying a novel evolutionary conserved SIRT1-FoxO1 axis that regulates CD8+ memory T cell metabolism and cytotoxicity. His last day in the Ott Lab was July 31st, and he is now off to work for Bristol-Meyers Squibb.

Congratulations, Ansu, and good luck at your new job!